@article{oai:nagasaki-u.repo.nii.ac.jp:00027531,
 author = {Kawano, Hiroaki and Motokawa, Tetsufumi and Kurohama, Hirokazu and Okano, Shinji and Akashi, Ryohei and Yonekura, Tsuyoshi and Ikeda, Satoshi and Izumikawa, Koichi and Maemura, Koji},
 issue = {15},
 journal = {Internal Medicine},
 month = {Aug},
 note = {A 60-year-old Japanese woman was hospitalized for cardiogenic shock 24 days after receiving the second dose of the coronavirus disease 2019 BNT162b2 vaccine. Impella CP left ventricular assist device implantation and venoarterial peripheral extracorporeal membranous oxygenation were immediately initiated along with inotropic support and steroid pulse therapy, as an endomyocardial biopsy specimen showed myocarditis. Three weeks later, her cardiac function had recovered, and she was discharged. An immune response associated with the presence of spike protein in cardiac myocytes may be related to myocarditis in the present case because of positive immunostaining for severe acute respiratory syndrome coronavirus 2 spike protein and C4d in the myocardium., Internal Medicine, 61 (15), pp. 2319-2325; 2022},
 pages = {2319--2325},
 title = {Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination},
 volume = {61},
 year = {2022}
}